Viewing Study NCT02489903

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:23 PM
Ignite Modification Date: 2026-02-23 @ 8:08 PM
Study NCT ID: NCT02489903
Status: COMPLETED
Last Update Posted: 2025-03-17
First Post: 2015-06-29
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
Sponsor: EpicentRx, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Small Cell Carcinoma View
None Carcinoma, Non-Small-Cell Lung View
None Neuroendocrine Tumors View
None Ovarian Epithelial Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Epigenetics View
None resensitization View
None Platinum doublets View
None lung cancer View
None Ovarian epithelial cancer View